Sponsor:
Seagen Inc.
Code:
NCT05194072
Conditions
Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Triple Negative Breast Neoplasms
HER2 Negative Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SGN-B7H4V
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations